Production (Stage)
Seres Therapeutics, Inc.
MCRB
$7.09
$0.040.57%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 58.85M | 30.79M | 66.82M | 71.23M | 111.18M |
| Total Receivables | 2.76M | 2.07M | -- | 18.60M | 7.42M |
| Inventory | -- | -- | -- | 53.00M | 41.97M |
| Prepaid Expenses | 4.47M | 5.81M | 6.10M | 6.44M | 4.61M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 66.08M | 38.67M | 72.93M | 149.27M | 165.18M |
|
|
|||||
| Total Current Assets | 66.08M | 38.67M | 72.93M | 149.27M | 165.18M |
| Net Property, Plant & Equipment | 89.41M | 92.44M | 95.48M | 121.08M | 124.78M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 8.70M | 8.70M | 10.34M | 51.39M | 51.30M |
| Total Assets | 164.18M | 139.81M | 178.74M | 321.73M | 341.26M |
|
|
|||||
| Total Accounts Payable | 2.17M | 4.08M | 8.25M | 4.81M | 5.22M |
| Total Accrued Expenses | 6.22M | 10.72M | 17.72M | 43.28M | 40.11M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 9.05M | 8.67M | 8.35M | 9.20M | 8.83M |
| Total Finance Division Other Current Liabilities | 13.89M | 17.75M | 30.52M | 51.00M | 44.32M |
| Total Other Current Liabilities | 13.89M | 17.75M | 30.52M | 51.00M | 44.32M |
| Total Current Liabilities | 31.32M | 41.22M | 64.83M | 108.28M | 98.48M |
|
|
|||||
| Total Current Liabilities | 31.32M | 41.22M | 64.83M | 108.28M | 98.48M |
| Long-Term Debt | -- | -- | -- | 102.49M | 102.01M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 80.50M | 82.97M | 85.27M | 100.94M | 103.34M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 1.90M | 1.84M | 4.72M | 97.09M | 97.17M |
| Total Liabilities | 113.72M | 126.03M | 154.82M | 408.81M | 401.00M |
|
|
|||||
| Common Stock & APIC | 995.88M | 991.88M | 986.38M | 964.16M | 958.63M |
| Retained Earnings | -945.42M | -978.10M | -962.46M | -1.05B | -1.02B |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 50.47M | 13.78M | 23.92M | -87.07M | -59.74M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 50.47M | 13.78M | 23.92M | -87.07M | -59.74M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 50.47M | 13.78M | 23.92M | -87.07M | -59.74M |
|
|
|||||